New findings show positive airway pressure (PAP) therapy reduced risks of death and hospitalization for patients with obstructive sleep apnea (OSA) Prevalence of OSA in the United States expected to ...
Safety Signal of Increased Cardiovascular Mortality Found For ASV Therapy In People With Predominant Central Sleep Apnea and Symptomatic Chronic Heart Failure SAN DIEGO, May 13 /PRNewswire/ -- ResMed ...
Media questions/requests: Peter Duckler, +1 (773) 343-3069, [email protected] Rowena Kelley, +1 (858) 289-7272, [email protected] Source: ResMed Inc. 2024 GlobeNewswire, Inc.
On May 15, 2015, Respironics, Inc., a Philips business, provided the following response to ResMed's Update on Phase IV SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy in Central Sleep Apnea ...
SAN DIEGO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) launched today its AirCurve 11 series devices, the company’s newest bilevel devices that use two levels of support, ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: ResMed Inc. has initiated ...
People with obstructive sleep apnea may have a higher risk of developing Parkinson’s disease, but early use of continuous positive airway pressure (CPAP) therapy could help lower that risk. A ...
DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ — As sleep disorders such as obstructive sleep apnea (OSA), chronic snoring, and breathing ...
Loud snoring at night. Pauses in breathing followed by gasps for air while you’re asleep. Excessive daytime fatigue. Frequent nodding off in front of the TV or even when behind the wheel of a car.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results